EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Osiris Therapeutics, Inc.
November 24 2015 - 7:07PM
Business Wire
Rosen Law Firm, a global investor rights law firm, announces
that it has filed a class action lawsuit on behalf of purchasers of
Osiris Therapeutics, Inc. (NASDAQ:OSIR) securities from May 12,
2014 through November 20, 2015, all dates inclusive (the “Class
Period”). The lawsuit seeks to recover damages for Osiris investors
under the federal securities laws.
To join the Osiris class action, go to the firm’s website at
http://rosenlegal.com/cases-786.html or call Phillip Kim, Esq. or
Kevin Chan, Esq. toll free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for more information on
the class action. The case is pending in the U.S. District Court
for the Southern District of New York.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants
issued false and misleading statements to investors and/or failed
to disclose that: (1) Osiris improperly recognized revenue under
contracts it had with its distributors; (2) Osiris’ disclosure
controls and procedures were not effective as of December 31, 2014,
March 31, 2015, and June 30, 2015; and (3) as a result, defendants’
statements about Osiris’ business and prospects were materially
false and misleading and/or lacked a reasonable basis at all
relevant times. When the true details entered the market, the
lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
January 22, 2016. A lead plaintiff is a representative party acting
on behalf of other class members in directing the litigation. If
you wish to join the litigation, go to the firm’s website at
http://rosenlegal.com/cases-786.html for more information. You may
also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law
Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com
or kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151124006358/en/
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212)
202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Sep 2023 to Sep 2024